Colorectal 2 week wait pathways and “Getting FIT”

Slides:



Advertisements
Similar presentations
This short questionnaire will help to determine whether there may be a gene in your family connected to an increased risk of the development of bowel.
Advertisements

Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
New Pathways to Diagnosis November 2013 Ed Seward on behalf of theDiagnostics Group Phil AndrewsColorectal Pathway London Cancer
The Recovery Package Hayley Williams Macmillan Survivorship Programme Manager South Yorkshire Bassetlaw and North Derbyshire Dr Anthony Gore GP Cancer.
Direct Access Flexible Sigmoidoscopy Pathway for GPs
Oesophageal Cancer. -improving outcomes. Anil Kaul Consultant General and Upper GI Surgery St Helens and Knowsley Teaching Hospitals NHS Trust.
School for Primary Care Research Increasing the evidence base for primary care practice The School for Primary Care Research is a partnership between the.
Ian Arnott Consultant Gastroenterologist Western General Hospital Edinburgh The Use of Faecal Calprotectin in Primary Care.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Upper and Lower GI Investigation of Elderly Patients who are Iron Deficient American Journal of Medicine July 1999.
Upper GI 2WW referrals & open access endoscopy Dr Amanda J Hughes.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Iron deficiency anaemia Christian Selinger Consultant Gastroenterologist.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
Colorectal Pathway North Bristol NHS Trust. Background Colorectal pathway introduced in 2006 Shorten patient pathway Straight to test Reduce routes into.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
Direct Access Flexible Sigmoidoscopy
MARK COLEMAN MBChB FRCS (Gen Surg) MD hon FRCPSG Consultant Colorectal Surgeon
Endoscopy Matters NICE guidance dyspepsia, New build, National Context & NAEDI Dr Michelle Gallagher Consultant Gastroenterologist.
Bowel Cancer Screening in West Herts- The First 2 Years! Alistair King Consultant Gastroenterologist.
Definition Signs & symptoms Treatment Root of the disease.
Flexible Sigmoidoscopy And Whole Colon Imaging In The Diagnosis Of Cancer In Patients With Colorectal Symptoms Peter O’Leary Journal Club 13/10/08.
Interventions for Clients with Colorectal Cancer.
Update The 2 week rule for colorectal cancer Mr Iain Jourdan MS FRCS Director of Surgery Royal Surrey County Hospital.
Camden & Islington Practice Nurse/HCA Event Gali Siegal Health Professional Engagement Facilitator Haringey and Enfield March 2016.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
Fast Track Referrals – Paisley, Rosemary and Time Nick Sharer May 2015.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
FIT Programme (Faecal Immunohistochemical Test)
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
The Use of Faecal Calprotectin in Primary Care
The capacity challenge:
An Electronic 2 Week Wait Referral System for Colorectal Cancer
Cancer Audit Stourport Health Centre Feb 2016
New NICE Guidance There are many combinations of symptoms to consider now but in order to use ICE it is important that you start with the main symptom.
Upper Gastrointestinal Cancers Top ⑩ Tips
بسم الله الرحمن الرحيم.
IDA – Lessons from our local service
Colorectal Cancer: Risk Prevention and Diagnosis
Camden Two Week Wait Referrals Feedback
‘Piloting change’ report on the Multi Disciplinary Diagnostic centre
Presenting with IBS symptoms, baseline assessment.
Bowel cancer screening update GP education event 28 Nov 2017
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
Common cancers and NICE
Colorectal Cancer.
Colorectal Cancer Mr Eoghan Condon, MD,FRCSI.
Mr Michael Thomas, Colorectal Cancer SSG, 27th June 2018
BOWEL CANCER SCREENING 11/7/18
Direct Access Colonoscopy Service (DACS)
National Cancer Diagnosis Audit
What to look out for and why?
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Somerset, Wiltshire, Avon & Gloucestershire Cancer Alliance
Colorectal Cancer Cancer Alliance Work
Worcestershire Colorectal Cancer 2ww Pathway
Currently You send pts for colonoscopy
The Use of Faecal Calprotectin in Primary Care
FIT for symptomatic patients
A good MDT MDT working is considered the gold standard for cancer patient management bringing continuity of care and reducing variation in access.
Nursing care of patients operated-on for CRC
Colorectal and General Surgical Topics Relevant to GPs GP update meeting Addington Practice Tuesday 26th March 2014 Mr Steve Warren.
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway
A good MDT MDT working is considered the gold standard for cancer patient management bringing continuity of care and reducing variation in access.
Patients referred under UGI 2WW
Suspected Gynaecological Cancer Recognition & Referral
NHS Long Term Plan: Rapid Diagnostic Centres (RDC) The SWAG Approach
NCA Colorectal Symptoms Assessment Pathway for Primary Care
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway Guidance for investigating colorectal symptoms in primary care including IDA , Faecal.
Faecal Immunochemistry Test - qFIT
Presentation transcript:

Colorectal 2 week wait pathways and “Getting FIT”

The two week Cancer Pathway 14 days 17 days 31 days Time to see in clinic Time to make diagnosis Time to start treatment

Earlier diagnosis Five year Forward View Improving Outcomes: a strategy for Cancer The likely impact of earlier diagnosis of cancer on costs and benefits in the NHS

Nottingham Cancers

Staging Matters

2 Week Wait referrals

New referral form

Co-morbidity

2WW pathway Introduced in 2000 Based on symptoms Not very effective locally and nationally Continually rising referral rates with no evidence of earlier stage detection (compare with BCSP) Evidence of reduced emergency presentation Low rates of cancer diagnosis & almost as many diagnoses from non-2WW referrals High rates of normal results from invasive tests Multiple symptoms have higher specificity than single symptoms but often diagnose later stage tumours Patients present with CIBH have cancer diagnosis excluded but get no help with their symptoms T1 rectal polyp cancer (BCSP)

Direct to test (DTT) The 2WW pathway has become a “CRC exclusion” pathway 150 - 180 referrals/month at NUH only (not TC) Pre-DTT: Overwhelming majority seen by Colorectal Nurse Practitioners independently with limited Consultant input DTT introduced in August 2014 to expedite diagnosis and introduce Consultant vetting

Direct To Test (DTT)

Outcomes Only 39-71% 2WW referrals (wide monthly variation) actually satisfy 2WW referral criteria. “Change in bowel habit to looser stools/more frequent stools” We investigate anyway. 2015 data: 45-50% DTT 15-25% seen by Cons 25-35% Nurse 5-10% other Outcome Audit: 1st August – 30th November 2014 553 referrals Colorectal Cancer (incl. anal) diagnoses = 37(6.7%) DTT patients significantly Younger Quicker first investigation (12 v 23 days) Quicker tissue diagnosis (16 v 26 days) DTT patients twice as likely to have colonoscopy (87 v 42%) BUT rates of normal colonoscopy same in both groups The rate of cancer diagnosis (8.5%) in asymptomatic BCSP patients with abnormal gFOBT in same time period was higher than in our symptomatic 2WW patients.

Anaemia Audit of 1000 DTT referrals to NUH: 20% had no Hb done at referral 38% were anaemic at time of referral but 2/3 were referred for other reasons Anaemic patients with sx are 4.4 times more likely to have cancer than non-anaemic patients Anaemia with bowel symptoms is a better predictor of CRC – particularly Right sided cancer Fe deficiency anaemia particularly so

New NICE guidance (NG12) Symptom based Looser Which we know is poor particularly “change in bowel habit” Looser Lower specificity Increased demand on stretched services Clinic Endoscopy Radiology Non-symptom based Use of FOBT Not rectal bleeding >50yo abdo pain or weight loss <60yo with CIBH <60yo iron deficiency anaemia (??) >60yo anaemia without Fe deficiency Broadening screening by the back door?

No clarity on…. Which FOBT? gFOBT (subjective & categorical) or FIT (objective, more sensitive, quantitative but less specific the lower you go)? gFOBT was withdrawn as test in symptomatic patients due to poor clinical effectiveness Studies (mainly within BCSP) demonstrate FIT>>gFOBT BUT what level of blood in a FIT warrants ix? No consensus…as yet Normal levels of blood in FIT vary according to age, sex and geography We do not know what to advise you with patients who have intermediate levels of blood in a FIT test…..at present

“Getting FIT” Prospective service evaluation Collaborative Primary care Nottingham Colorectal Service Bowel Cancer Screening Hub Two pathways I: Evaluating FIT levels in patients without rectal bleeding in the 2WW pathway II: GP access to FIT in appropriate patients

The future Local and national questions: Can Negative Predictive Value of FIT be used to avoid unnecessary investigation? Can FIT and anaemia be used to stratify referrals into high and low risk? Can CT colon reduce need for Colonoscopy? Is whole colon investigation necessary in absence of abdominal mass, anaemia and/or negative FIT?

Take home messages Please use the right form AND please request bloods on 2WW or “Getting FIT” referral FBC, UE and CRP BUT NOT CEA DTT team will check the results Please do not ask for FIT (or any FOBT) on Patients with rectal bleeding Patients over 60yo: they can call BCSP for a standard gFOBT kit “Negative”FOBT results DO NOT exclude cancer We would prefer you refer Fe def anaemia on a 2WW pathway for now

Questions?